4.4 Article

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials

Carrol Gamble et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Medicine, General & Internal

Middle East Respiratory Syndrome

Yaseen M. Arabi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials

David Moher et al.

BMJ-BRITISH MEDICAL JOURNAL (2010)

Article Medicine, General & Internal

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

Kenneth F. Schulz et al.

BMJ-BRITISH MEDICAL JOURNAL (2010)

Article Mathematical & Computational Biology

Robustness of an odds-ratio test in a stratified group sequential trial with a binary outcome measure

Deo Kumar Srivastava et al.

BIOMETRICAL JOURNAL (2007)

Article Mathematical & Computational Biology

Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections

H Schäfer et al.

STATISTICS IN MEDICINE (2001)

Article Health Care Sciences & Services

Flexible interim analyses in clinical trials using multistage adaptive test designs

G Wassmer et al.

DRUG INFORMATION JOURNAL (2001)